Vivos Therapeutics said Wednesday the Food and Drug Administration has granted 510 clearance for its oral device treatment for severe obstructive sleep apnea in adults.
The clearance is for its.
Real-time index price for TSX Composite High Beta Index (TXHB), along with buy or sell indicators, analysis, charts, historical performance, news and more
Health care stocks were lower Wednesday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund 0.2% softer.
The iShares Biotechnology ETF was.
Vivos Therapeutics (NASDAQ:VVOS – Get Rating) and Orthofix Medical (NASDAQ:OFIX – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Volatility and Risk Vivos Therapeutics has a beta of […]
Vivos Therapeutics (NASDAQ:VVOS – Get Rating) and Orthofix Medical (NASDAQ:OFIX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, institutional ownership and valuation. Analyst Recommendations This is a breakdown of recent ratings […]